Coral Laboratories has informed that pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015, the meeting of the Board of Directors of the Company has been scheduled to be held on Monday, 12th August, 2019 at Corporate Office of Company at 3 B, Patanwala Compound, Next To Fitness World, L.B.S.Marg, Ghatkopar (W) Mumbai- 400 086 at 2.00 pm, to considering and adopting Unaudited Financial Results of the Company for the quarter ended 30th June, 2019 in terms of Regulation 33 of (LODR) Regulations, 2015; to fix the date for the 37th Annual General Meeting; to approve Draft Directors Report for the year ended 31st March,2019 along with the Notice of 37th Annual General Meeting; fixing of date of Book Closure for the purpose of Annual General Meeting; re-appointment of Sheela Kamdar (DIN: 06948522) as an Independent Director of the Company for the Second Term of five years; and any other business with the permission of chairman.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1644.50 |
| Dr. Reddys Lab | 1302.10 |
| Cipla | 1259.55 |
| Zydus Lifesciences | 938.55 |
| Lupin | 2322.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: